Background
Publisher
Springer Singapore
Reference60 articles.
1. Shulman ST. IVGG therapy in Kawasaki disease: mechanism(s) of action. Clin Immunol Immunopathol. 1989;53(2 Pt 2):S141–6.
2. Maddox RA, Holman RC, Uehara R, et al. Recurrent Kawasaki disease: USA and Japan. Pediatr Int. 2015;57:1116–20.
3. Aggarwal P, Suri D, Narula N, et al. Symptomatic myocarditis in Kawasaki disease. Indian J Pediatr. 2012;79(6):813–4.
4. De Rosa G, Andreozzi L, Piastra M, et al. Acute myocarditis as a revealing clue of complete Kawasaki disease. Reumatismo. 2018;70(2):115–6.
5. Okada S, Hasegawa S, Suzuki Y, et al. Acute pericardial effusion representing the TNF-α-mediated severe inflammation but not the coronary artery outcome of Kawasaki disease. Scand J Rheumatol. 2015;44(3):247–52.